Global Biosimilars Market

Global Biosimilars Market- By Product (Insulin, Interferon, Etanercept, Infliximab, Rituximab, Glucagon, Calcitonin), By Manufacturing (In-house, Contract), By Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease)and By Region (North America, Europe, Asia Pacific, South America, Middle East, & Africa)- Global forecast from 2020-2027.

Frequently Asked Questions (FAQ):

Biosimilars refer to a generic product that is very close in structure and function to a biological drug.

Riabni, Hulio, Nyvepria, Avsola, Semglee, etc., are examples of biosimilars.

The global biosimilars market size will reach USD 59.27 billion by 2027 from USD 13.54 billion in 2020.

The growth rate of the Global Biosimilars market is 23.7% during the forecast period.

The Cost-effectiveness of biosimilars and increase in Biosimilar treatment penetration are the growth drivers of the Global Biosimilars market.


Check Discount %


Free Sample Report